Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 251 to 260 of 1556

TitleReference numberPublishedLast updated
Ruxolitinib for treating polycythaemia veraTA921
Daridorexant for treating long-term insomniaTA922
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsTA927
Thyroid disease: assessment and managementNG145
Virtual ward platform technologies for acute respiratory infections: early value assessmentHTG697
Bimekizumab for treating axial spondyloarthritisTA918
Pegunigalsidase alfa for treating Fabry diseaseTA915
Bimekizumab for treating active psoriatic arthritisTA916
Ovarian cancer: recognition and initial managementCG122
Urinary incontinence in neurological disease: assessment and managementCG148

Results per page

  1. 10
  2. 25
  3. 50
  4. All